Transcatheter Aortic Valve Replacement Clinical Trial
Official title:
Safety, Applicability and Outcome of Regular Exercise Training After Transcatheter Aortic Valve Implantation
This pilot study will evaluate the effect of a rehabilitative exercise training on exercise capacity in patients after percutaneous aortic valve replacement. It will additionally evaluate the safety of such an approach and the effect on life quality. We hypothesize that regular structured exercise improves exercise capacity in these patients beyond the sole effect of the valve procedure.
The study will include 30 patients and randomize them in a 1:1-fashion to either a training or a usual care group. The training group will undergo 8 weeks of combined endurance and resistance training according to a standard protocol, but with individual adjustment if required. The usual care group will receive general advice but no structured exercise program. Exercise capacity is assessed by cardiopulmonary exercise testing and by the 6 minute walk test prior to and after the intervention period. In addition, life quality will be assessed by validated questionnaires, while safety will be assessed by recording adverse events and by echocardiography. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05465655 -
Cara CDRM (Conduction Disturbance Risk Monitor) 2.0
|
N/A | |
Recruiting |
NCT04870424 -
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
|
Phase 3 | |
Completed |
NCT02758964 -
Evaluation of Cerebral Thrombembolism After TAVR
|
||
Recruiting |
NCT05758701 -
CT TAVR Abdomen Study
|
Phase 4 | |
Active, not recruiting |
NCT04281771 -
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT04573049 -
The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
|
Phase 4 | |
Recruiting |
NCT05235555 -
EffecTAVI Registry
|
||
Completed |
NCT05082337 -
The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures
|
N/A | |
Completed |
NCT01627691 -
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System
|
N/A | |
Recruiting |
NCT05075590 -
Coronary Access After Supra-Annular THV Implantation
|
N/A | |
Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
Recruiting |
NCT05259241 -
ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI)
|
N/A | |
Completed |
NCT04489914 -
Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement
|
||
Recruiting |
NCT03649594 -
Risk Stratification Post TAVI Using TEG
|
||
Completed |
NCT04659538 -
The CAPTIS® Study - Embolic Protection in TAVR
|
N/A | |
Recruiting |
NCT04107038 -
Monitored Anesthesia Care vs. General Anesthesia for Transcatheter Aortic Valve Replacement
|
N/A | |
Withdrawn |
NCT04268160 -
GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR
|
||
Recruiting |
NCT02812953 -
Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention
|
||
Recruiting |
NCT05217888 -
The Sentinel Registry
|